Aller au contenu principal
Accès ouvert déclaré 2026 article

Antileishmanial Activity of Quercetin-ZnMgFe2O4 Nanostructure on Leishmania major in Vitro

0Citations signalées — pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Background: Cutaneous leishmaniasis is a neglected parasitic disease prevalent in tropical and subtropical regions, caused by different species of the genus Leishmania. Current therapeutic options are limited due to toxicity, prolonged treatment regimens, and emerging drug resistance. Methods: This study was conducted at Kashan University of Medical Sciences, Kashan, Iran in 2024. The antileishmanial activity of quercetin and a synthesized quercetin–ZnMgFe₂O₄ nanostructure was evaluated against L. major promastigotes in vitro conditions. The nanostructure was synthesized and characterized using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). The antileishmanial activity was assessed by determining the mortality rate of promastigotes at different concentrations (150, 300, 450, and 600 μg/mL) of quercetin and also quercetin–ZnMgFe₂O₄ nanostructure. In addition, ultrastructural and nuclear alterations were examined following exposure to 150 and 600 μg/mL of both quercetin and the nanostructure. Results: The quercetin–ZnMgFe₂O₄ nanostructure exhibited significantly higher inhibitory activity compared with quercetin. The mortality rates for the nanostructure were 73% and 85.9% at 150 and 600 μg/mL, respectively, compared with 42% and 81% for quercetin. Microscopic analysis revealed pronounced morphological alterations, including damage to the cell body and flagella, as well as destruction of the nucleus and kinetoplast. Conclusion: The Quercetin_ZnMgFe₂O₄ nanostructure exhibited considerable antileishmanial activity against L.major promastigotes in vitro. Considering the obtained results, this nanostructure can be considered in anti-leishmanial studies and further in vitro and in vivo investigations are required to evaluate its safety and efficacy.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Antileishmanial Activity of Quercetin-ZnMgFe2O4 Nanostructure on Leishmania major in Vitro
Date Crossref
20/07/2026
Éditeur
Knowledge E DMCC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Research on Leishmaniasis StudiesNonlinear Optical Materials ResearchChemical and Physical Properties of Materials

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.